The Brink's Company (BCO) SEC Filings & Earnings Calls
EquiReason read 21 The Brink's Company SEC filings in the last 12 months. Latest: 8-K on 2026-10-08 — 8-K Item 8.01 referencing a press release;.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 4.6B
- P/E TTM
- 25.8
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Aug 202610-QRevenue $1.39B (+7% y/y); Non-GAAP operating profit margin 13.6; Adjusted EBITDA $257M (+11% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $1.39B | +7% y/y |
| Non-GAAP operating profit margin · Q2-2026 | 13.6% | |
| Adjusted EBITDA · Q2-2026 | $257M | +11% y/y |
| Non-GAAP diluted EPS from continuing operations · Q2-2026 | $2.13 | +18% y/y |
| GAAP operating profit margin · Q2-2026 | 9.6% | |
| Capital expenditures · H1-2026 | $75M | -32% y/y |
| Free cash flow before dividends · H1-2026 | $32M | |
| Net Debt · 2026-06-30 | $2.73B |
Risks flagged
Acquisition and transformation execution risk
“NCR Atleos acquisition and transformation initiatives incurred $75.3 million in costs in H1 2026, up from $10.5 million in H1 2025.”
Foreign exchange exposure
“Favorable currency impact of $37.4 million in Q2 2026; future fluctuations could have negative impact.”
Regulatory and legal risks
“DOJ/FinCEN investigations and Chile antitrust matter continue to incur costs.”
5 Aug 20268-K · 2.02, 7.01Revenue $1.39B (+7% y/y); Non-GAAP Adjusted EBITDA $257M (+11% y/y); Non-GAAP EPS $2.13 (+18% y/y); Guidance: Q3 2026 Non-GAAP Adjusted EBITDA guidance $263-$283M; Non-GAAP EPS $2.23-$2.63earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $1.39B | +7% y/y |
| Non-GAAP Adjusted EBITDA · Q2-2026 | $257M | +11% y/y |
| Non-GAAP EPS · Q2-2026 | $2.13 | +18% y/y |
| GAAP EPS · Q2-2026 | $1.07 | +4% y/y |
| Operating profit margin (Non-GAAP) · Q2-2026 | 13.6% | |
| Free cash flow (trailing twelve months) · TTM-Q2-2026 | $468M |
Guidance
Q3 2026 Non-GAAP Adjusted EBITDA guidance $263-$283M; Non-GAAP EPS $2.23-$2.63
Full-year framework reaffirmed with mid-single digit organic revenue growth, AMS/DRS mid-to-high teens growth, 30-50bps EBITDA margin expansion, and 40-45% FCF conversion.
Risks flagged
Currency volatility risk due to international operations
“Management added quarterly guidance to clarify impact of near-term currency trends”
M&A integration risk for NCR Atleos acquisition
“Integration management teams continue to advance detailed planning to realize approximately $200 million in run-rate synergies” · word for word
24 Jul 20268-K · 7.01Brink's anticipates deconsolidation of Malaysia business, reducing reported revenue ~$100M and Adj. EBITDA ~$10-15M over next four quarters, with no impact on FY2026 organic growth and margin framework.open
Figures in the filing · each found in the filing text
| revenue · Malaysia Business · next four quarte | $100M | |
| Adjusted EBITDA · Malaysia Business · next four quarte | $10M |
Guidance
FY2026 organic revenue growth and Adjusted EBITDA margin expansion framework unchanged
Company reaffirms FY2026 organic growth and margin framework despite deconsolidation.
Risks flagged
Deconsolidation risk: change in accounting treatment may signal reduced control or operational change in Malaysia.
“anticipates a change in the accounting treatment with respect to its Malaysia business” · word for word
30 Jun 20268-K · 5.07, 7.01Submitted matters to a vote of security holders; issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Merger integration risk; substantial debt to finance merger; regulatory approvals pending
“Forward-looking statements list risks: ability to consummate mergers, financing, regulatory approvals, integration, customer/employee retention.”
18 Jun 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
Shareholder litigation risk related to merger disclosures; potential delay or injunction.
“two complaints challenging the Mergers have been filed by purported stockholders of NCR Atleos” · word for word
2 Jun 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Guidance
Reiterated previously disclosed guidance; no new numbers.
6 May 202610-QRevenue $1.38B (+10% y/y); Non-GAAP operating profit $168M (+12% y/y); Non-GAAP operating profit margin 12.2open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $1.38B | +10% y/y |
| Non-GAAP operating profit · Q1-2026 | $168M | +12% y/y |
| Non-GAAP operating profit margin · Q1-2026 | 12.2% | |
| Adjusted EBITDA · Q1-2026 | $238M | +10% y/y |
| Non-GAAP diluted EPS from continuing operations · Q1-2026 | $1.80 | +11% y/y |
| Capital expenditures · Q1-2026 | $40M | -32% y/y |
| Free cash flow before dividends · Q1-2026 | $-36M | +65% y/y |
| Net Debt · 2026-03-31 | $2.74B |
Risks flagged
Acquisition integration risk
“NCR Atleos acquisition and transformation initiatives ($38.9 million) incurred in Q1 2026, with transaction expected to close in Q1 2027.”
Foreign exchange exposure
“Favorable currency impact of $71.1 million on revenue, but future fluctuations could have negative impact.”
Legal and regulatory costs
“Non-routine legal matters ($2.8 million), DOJ/FinCEN investigations ($1.2 million), Chile antitrust matter ($0.2 million) incurred in Q1 2026.”
6 May 20268-K · 7.01Revenue $1.38B (+10% y/y); Adjusted EBITDA $238M (+10% y/y); Non-GAAP EPS $1.80 (+11% y/y); Guidance: FY2026 framework: mid-single-digit organic growth, 30-50bps margin expansion, 40-45% FCF conversion; Q2 guidance providedopen
Figures in the filing · each found in the filing text
| Revenue · total · Q1-2026 | $1.38B | +10% y/y |
| Adjusted EBITDA · total · Q1-2026 | $238M | +10% y/y |
| Non-GAAP EPS · total · Q1-2026 | $1.80 | +11% y/y |
| GAAP operating profit · total · Q1-2026 | $110M | -7% y/y |
| Non-GAAP operating profit · total · Q1-2026 | $168M | +12% y/y |
| GAAP net income · total · Q1-2026 | $32M | -38% y/y |
| GAAP EPS · total · Q1-2026 | $0.77 | -35% y/y |
| Free cash flow improvement · total · Q1-2026 | $66M |
Guidance
FY2026 framework: mid-single-digit organic growth, 30-50bps margin expansion, 40-45% FCF conversion; Q2 guidance provided
Reaffirmed FY2026 framework with mid-single-digit organic growth and margin expansion; provided Q2 guidance.
Risks flagged
Currency volatility impacting results; additional guidance provided to clarify
“Management added quarterly guidance to clarify impact of near-term currency trends.”
Integration risk from NCR Atleos acquisition
“Acquisition on track but integration management team still in planning phase.”
GAAP profitability decline due to non-GAAP adjustments
“GAAP net income down 38%, GAAP EPS down 35%.”
4 May 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen
Risks flagged
Potential dilution from new equity plan shares, but standard governance item.
“adds 3,900,000 shares of the Company's common stock available for issuance under the plan” · word for word
6 Apr 20268-K · 1.01, 2.03, 7.01Brink's amended and extended its credit facility from $2.225B to $3.85B, including a $1.025B delayed draw term loan and $600M revolver increase, to fund the NCR Atleos acquisition.open
Figures in the filing · each found in the filing text
| Credit facility size · Q1-2026 | $3.85B | |
| Delayed draw term loan · Q1-2026 | $1.02B | |
| Revolving credit commitment increase · Q1-2026 | $600M |
Risks flagged
Increased leverage from acquisition financing may pressure credit metrics.
“Credit facility increased by $1.625B; acquisition subject to regulatory and shareholder approvals.”
20 Mar 2026DEF 14AProxy statement for 2026 annual meeting detailing executive compensation, incentive plan metrics, and a proposal to increase equity plan share reserve.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $5.26B | |
| Net income attributable to Brink's · FY2025 | $200M | |
| Adjusted EBITDA · FY2025 | $977M | |
| GAAP operating profit · FY2025 | $586M | |
| Non-GAAP operating profit · FY2025 | $710M | |
| GAAP net cash from operations · FY2025 | $640M | |
| Free cash flow before dividends · FY2025 | $436M | |
| GAAP EPS · FY2025 | $4.70 | |
| Non-GAAP EPS · FY2025 | $8.05 | |
| AMS/DRS Revenue · AMS/DRS · FY2025 | $1.46B |
Risks flagged
Precious Metals Volatility Distortion
“A portion of the Company’s financial performance reflected benefits from unusual volatility in precious metals markets, primarily driven by changes in the U.S. tariff regime. This volatility had a disproportionate impact across certain regions, particularly in the United States and Europe, and was not reflective of underlying operational performance or execu” · word for word
Uneven Regional Performance
“The Company experienced uneven performance across geographic regions, resulting in foreign exchange — driven revenue contributions that did not translate into commensurate incremental profitability.” · word for word
Key Person/Retention Risk (CEO)
“Given the focus by the Board on emphasizing retention and ensuring appropriate and seamless succession planning in accordance with the strategy and direction of the Company, in 2025, the Compensation Committee approved a letter agreement with Mr. Eubanks that provides him with certain vesting treatment for his future annual equity awards, performance stock u” · word for word
26 Feb 20268-K · 1.01, 7.01Brink's to acquire NCR Atleos for $6.6B in cash and stock, creating a leading fintech infrastructure company; expected 35% EPS accretion, $200M cost synergies, $10B combined revenue.acquisitionopen
Figures in the filing · each found in the filing text
| Total Revenue (combined company) · FY2026 | $10.00B | |
| Cost Synergies (annual run-rate) · FY2027 | $200M | |
| EPS Accretion · FY2027 | 35.0% | |
| Implied Value per NCR Atleos Share · point_in_time | $50.40 | |
| Premium over NCR Atleos Closing Price · point_in_time | 24.0% | |
| NCR Atleos ATM Installed Base · point_in_time | 600,000 | |
| NCR Atleos Owned and Operated ATMs · point_in_time | 78,000 | |
| Brink's Shares Issued · point_in_time | 13,300,000 | |
| Cash Consideration · point_in_time | $2.20B | |
| Debt Assumed · point_in_time | $2.60B |
Risks flagged
Integration risk from combining two large organizations with global operations.
“Merger of two companies with operations in over 140 countries; integration complexity is high.”
Debt leverage increase from financing the cash portion of the acquisition.
“Cash portion financed with new debt; net leverage expected to be reduced to 2.0-3.0x by end of 2027.”
26 Feb 202610-KRevenue $5.26B (+5% y/y); Adjusted EBITDA $977M (+7% y/y); GAAP Operating Profit $586M (+29% y/y)open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $5.26B | +5% y/y |
| Adjusted EBITDA · FY2025 | $977M | +7% y/y |
| GAAP Operating Profit · FY2025 | $586M | +29% y/y |
| Non-GAAP Operating Profit · FY2025 | $710M | +13% y/y |
| Non-GAAP Diluted EPS from Continuing Operations · FY2025 | $8.05 | +12% y/y |
| GAAP Diluted EPS from Continuing Operations · FY2025 | $4.70 | +30% y/y |
| Share Repurchase Authorization · FY2025 | $750M | +50% y/y |
Risks flagged
Latin America Currency Exposure
“unfavorable impact of currency exchange rates ($98.5 million), primarily from the Argentine peso, Mexican peso, and Brazilian real” · word for word
Argentina Highly Inflationary Accounting
“Argentina highly inflationary impact: $10.2 million in pretax charges in 2025”
DOJ/FinCEN Investigation Costs
“DOJ/FinCEN investigations: $6.5 million in 2025”
26 Feb 20268-K · 2.02, 7.01Revenue $5.26B (+5% y/y); Revenue (Q4) $1.38B (+9% y/y); Adjusted EBITDA $977M (+7% y/y); Guidance: Mid-single-digit organic revenue growth, 30-50bps margin expansionearningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $5.26B | +5% y/y |
| Revenue (Q4) · Q4-2025 | $1.38B | +9% y/y |
| Adjusted EBITDA · FY2025 | $977M | +7% y/y |
| Adjusted EBITDA (Q4) · Q4-2025 | $277M | +10% y/y |
| Free Cash Flow · FY2025 | $436M | |
| Cash from Operations · FY2025 | $640M | |
| GAAP Net Income · FY2025 | $200M | +23% y/y |
| GAAP EPS · FY2025 | $4.70 | +30% y/y |
| Non-GAAP EPS · FY2025 | $8.05 | +12% y/y |
| Adjusted EBITDA Margin · FY2025 | 18.6% |
Guidance
Mid-single-digit organic revenue growth, 30-50bps margin expansion
2026 framework indicates continued growth momentum with mid-single-digit organic revenue growth, AMS/DRS mid-to-high teens growth, margin expansion, and strong FCF conversion.
Risks flagged
Currency volatility could impact reported results; company provided additional guidance to clarify currency impacts.
“Management has included additional guidance to better help investors understand currency impacts on our results.” · word for word
9 Jan 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Key accounting leadership departure may cause temporary disruption in financial reporting
“Chief Accounting Officer departure; CFO serving as acting replacement”
11 Dec 20258-K · 8.01Share repurchase authorization $750Mopen
Figures in the filing · each found in the filing text
| share repurchase authorization · 2025-12-10 | $750M |
Risks flagged
No specific risks disclosed beyond standard forward-looking statements.
5 Nov 20258-K · 2.02, 7.01Revenue $1.33B (+6% y/y); GAAP operating profit $152M (+37% y/y); Non-GAAP operating profit $188M (+24% y/y); Guidance: Q4 2025 revenue $1.33B-$1.38B; Adjusted EBITDA $267M-$287M; Non-GAAP EPS $2.28-$2.68earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $1.33B | +6% y/y |
| GAAP operating profit · Q3-2025 | $152M | +37% y/y |
| Non-GAAP operating profit · Q3-2025 | $188M | +24% y/y |
| GAAP operating profit margin · Q3-2025 | 11.4% | |
| Non-GAAP operating profit margin · Q3-2025 | 14.1% | |
| GAAP net income · Q3-2025 | $36M | +26% y/y |
| Adjusted EBITDA · Q3-2025 | $253M | +17% y/y |
| GAAP EPS · Q3-2025 | $0.86 | +32% y/y |
| Non-GAAP EPS · Q3-2025 | $2.08 | +28% y/y |
Guidance
Q4 2025 revenue $1.33B-$1.38B; Adjusted EBITDA $267M-$287M; Non-GAAP EPS $2.28-$2.68
2025 framework includes mid-single-digit organic revenue growth, AMS/DRS mid-to-high teens growth, and 30-50bps EBITDA margin expansion.
Risks flagged
Currency volatility and macroeconomic conditions could impact results.
“Management includes guidance for currency impacts; Q4 guidance assumes current economic trends.”
5 Nov 202510-QBrink's reported strong Q3 2025 results with 6% revenue growth, 24% non-GAAP operating profit growth, and margin expansion, partially offset by FX headwinds and a higher tax rate.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $1.33B | +6% y/y |
| Non-GAAP operating profit · Q3-2025 | $188M | +24% y/y |
| Adjusted EBITDA · Q3-2025 | $253M | +17% y/y |
| Non-GAAP diluted EPS from continuing operations · Q3-2025 | $2.08 | +28% y/y |
| Free cash flow before dividends · 9M-2025 | $174M | +78% y/y |
Risks flagged
Foreign exchange risk
“unfavorable changes in currency exchange rates on segment profit ($16.9 million), primarily driven by the Argentine peso and Mexican peso” · word for word
Tax law change risk
“As a result of the enactment of the OBBBA, we recorded a tax expense of $18.7 million from an increased valuation allowance on U.S. tax credit carryforwards.” · word for word
Argentina hyperinflation risk
“Argentina highly inflationary impact $9.1 million in 9M 2025”
The Brink's Company — questions
- What did The Brink's Company file recently?
- 21 SEC filings in the last 12 months. Latest: 8-K on 2026-10-08 — 8-K Item 8.01 referencing a press release;
Every figure on this page comes from The Brink's Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.